Evidence map›Paper›PMID 41648330›Full record

ArticlebioRxiv : the preprint server for biology2026

Tourette disorder features pervasive neuronal and glial transcriptional remodeling in the dorsolateral prefrontal cortex.

Philip J Moos, Caterina Branca, Teresa Musci, Giulia Braccagni, Easton van Luik, Marco Bortolato

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Philip J MoosDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Caterina BrancaDepartment of Cellular and Systems Pharmacology, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Teresa MusciDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Giulia BraccagniDepartment of Cellular and Systems Pharmacology, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Easton van LuikDepartment of Cellular and Systems Pharmacology, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Marco BortolatoDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Exploring the role of neuroactive steroids in Tourette syndromeR21NS125654 · NINDS · UNIVERSITY OF UTAH · PI BORTOLATO, MARCO, COFFEY, BARBARA JANE · 2022 to 2023
$459k
NCI NIH HHS P30 CA042014NINDS NIH HHS R21 NS125654
6 · The paper itself

Abstract

Tourette disorder (TD) is a neurodevelopmental condition with a robust genetic basis, characterized by multiple motor and vocal tics. Tics arise from dysfunction within cortico-striatal-thalamo-cortical circuits, with pathological evidence largely implicating striatal interneuron deficits and microglial activation. Recently, the largest genome-wide association study (GWAS) meta-analysis of TD identified polygenic risk enrichment in Brodmann area 9 (BA9), corresponding to the dorsolateral prefrontal cortex (DLPFC), a region implicated in executive control and tic suppression. However, the molecular landscape of BA9 in TD remains unexplored. Here, we performed single-nucleus RNA sequencing of postmortem BA9 from five males with TD and five matched controls, yielding 72,340 nuclei across neuronal and glial populations. While cell-type proportions were preserved, transcriptional remodeling was pervasive. In particular, biosynthetic and translational programs were upregulated across microglia, interneurons, oligodendrocytes, and superficial- and middle-layer excitatory neurons. Most cell types showed enrichment for glucocorticoid-responsive and immediate early gene modules consistent with stress-associated transcriptional activation. Finally, cross-regional comparison with striatal datasets revealed conservation of microglial and oligodendrocyte programs. These findings point to extensive transcriptional reprogramming in the DLPFC of individuals with TD, characterized by stress-associated activation, most strongly in oligodendrocytes and neurons.

Indexed as

dorsolateral prefrontal cortexpolygenic risk enrichmentsingle-nucleus transcriptomicsstress-responsive transcriptionTourette disordertranscriptional remodeling

Identifiers

PMID41648330
PMCPMC12871216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.